The manufacturer of Naturcold is listed on the packet as Fraken International (England), but the UK regulator told WHO that no such company exists.
The WHO wrote to India's regulator as the alert was issued on Wednesday, asking for help in reaching Indian companies that may be involved, a spokesperson told Reuters. Other countries have also been contacted, she said.
The alert about Naturcold is the latest of several similar warnings issued in recent months about contaminated cough syrups sold worldwide.
In 2022, the medicines were linked to the deaths of more than 300 children in Gambia, Uzbekistan and Indonesia. Another alert earlier this year also said contaminated medicines had been found in the Marshall Islands and Micronesia, but no deaths have been reported there. The WHO has said the threat is ongoing.
All of the syrups are made by different manufacturers, although in three of the four incidents, they are Indian-made.
The WHO said this pattern meant that working with India was a high priority in finding out more about the incident in Cameroon. It previously said efforts to find out more about the cough syrup incidents and the supply chains involved had been stymied by a lack of information from the Indian authorities and drugmakers.
Officials in India and Cameroon did not immediately respond to requests for comment.
(Reporting by Jennifer Rigby in London; Additional reporting by Krishna N.Das in New Delhi and Amindeh Blaise Atabong; Editing by David Holmes)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)